Tactile Systems Technology, Inc. (TCMD): Kapitalisasi marang pendapatan
Tactile Systems Technology (TCMD) minimizes manufacturing defects and waste, maintaining its market position through patents and insurance reimbursements. On GURU.Markets, the P/S ratio line chart captures the impact of these factors, where 1.70 serves as the final level marker. The company is currently focusing on implementing digital services for lymphedema treatment monitoring while expanding its line of pneumatic systems.
Rincian analitis perusahaan Tactile Systems Technology (TCMD)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Tactile Systems Technology|TCMD - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas tactilemedical.com|TCMD - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Tactile Systems Technology Inc.|TCMD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Tactile Medical|Rasio jangkoan perantara tactilemedical.com
- data bathi lan kelipatan valuasi:
TCMD - Bathi resik|Bathi resik sing dikarepake Tactile Systems Technology|TCMD - Rasio rega marang bathi|Pangali forward rega marang bathi tactilemedical.com|TCMD - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Tactile Systems Technology Inc.|TCMD - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Tactile Medical|TCMD - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan tactilemedical.com|TCMD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Tactile Systems Technology
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:TCMD Tactile Systems Technology, Inc.
When assessing the asset quality of Tactile Systems Technology (TCMD), it is essential to consider the high level of protection within their market niche provided by patents for lymphedema treatment systems. By analyzing the P/S multiple trend, an investor determines the market value of one dollar of revenue, which allows for an assessment of the premium attributed to insurmountable barriers to entry in the medtech sector and prevents unjustified capital overvaluation at the peak of the trend.
Pesaing Tactile Systems Technology
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|PFSA (Profusa Inc) - Kapitalisasi marang pendapatan|SSKN: Kapitalisasi marang volume dodolan|GCTK (GlucoTrack, Inc.) - Multiplikator P/S|Multiplikator P/S nanovibronix.com|Multiplikator P/S VERO|Kapitalisasi marang pendapatan Nuwellis Corp NUWE|Aethlon Medical - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ASXC (Asensus Surgical Inc)|Avinger - Multiplikator P/S|Koefisien rega marang pendapatan BioSig BSGM|Cutera, Inc (CUTR) - Rasio rega marang pendapatan|KNW (Know Labs Corporation) - Rasio rega marang pendapatan|NARI (Inari Medical, Inc.) - Multiplikator P/S|Rega marang dodolan nevro.com NVRO|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan
